Autopsy-Confirmed Familial Early-Onset Alzheimer Disease Caused by the L153V Presenilin 1 Mutation | Dementia and Cognitive Impairment | JAMA Neurology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
1.
Hardy  J Amyloid, the presenilins and Alzheimer's disease.  Trends Neurosci.1997;20:154-159.Google Scholar
2.
Cruts  MHendriks  LVan Broeckhoven  C The presenilin genes: a new gene family involved in Alzheimer disease pathology.  Hum Mol Genet.1996;5:1449-1455.Google Scholar
3.
Tysoe  CWhittaker  JXuereb  J  et al A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease.  Am J Hum Genet.1998;62:70-76.Google Scholar
4.
Raux  GGantier  RMartin  C  et al A novel presenilin 1 missense mutation (L153V) segregating with early-onset autosomal dominant Alzheimer's disease.  Hum Mutat.2000;16:95. Google Scholar
5.
Wechsler  D Manual for the Wechsler Adult Intelligence Scale, Revised.  New York, NY: Psychological Corp; 1981.
6.
Nelson  HEWillison  J The National Adult Reading Test (NART) Manual.  Windsor, Ontario: NFER-Nelson; 1991.
7.
Warrington  EK Manual for the Recognition Memory Test for Words and Faces.  Windsor, Ontario: NFER-Nelson; 1984.
8.
Coughlan  AKWarrington  EK Word-comprehension and word-retrieval in patients with localized cerebral lesions.  Brain.1978;101:163-185.Google Scholar
9.
Oldfield  RCWingfield  A Response latencies in naming objects.  Q J Exp Psychol.1965;18:273-281.Google Scholar
10.
Warrington  EKJames  M Visual apperceptive agnosia: a clinico-anatomical study of three cases.  Cortex.1988;24:13-32.Google Scholar
11.
Warrington  EKJames  M The Visual Object and Space Perception Battery.  Bury St Edmunds, England: Thames Valley Test Co; 1991.
12.
Folstein  MFolstein  SMcHughs  P The "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician.  J Psychiatr Res.1975;12:189-198.Google Scholar
13.
Weigl  E On the psychology of the so called process of abstraction.  J Abnorm Psychol.1948;36:3-33.Google Scholar
14.
Alzheimer's Disease Collaborative Group The structure of the presenilin I (S182) gene and identification of six novel mutations in early onset Alzheimer's disease families.  Nat Genet.1995;11:219-222.Google Scholar
15.
Cruts  MBackhovens  HWang  SY  et al Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3.  Hum Mol Genet.1995;4:2363-2371.Google Scholar
16.
Crook  REllis  RShanks  M  et al Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation.  Ann Neurol.1997;42:124-128.Google Scholar
17.
Boteva  KVitek  MMitsuda  H  et al Mutation analysis of presenillin 1 gene in Alzheimer's disease.  Lancet.1996;347:130-131.Google Scholar
18.
Dumanchin  CBrice  ACampion  D  et alfor the French Alzheimer's Disease Study Group De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases.  J Med Genet.1998;35:672-673.Google Scholar
19.
Campion  DFlaman  JMBrice  A  et al Mutations of the presenilin I gene in families with early-onset Alzheimer's disease.  Hum Mol Genet.1995;4:2373-2377.Google Scholar
20.
Sandbrink  RZhang  DSchaeffer  S  et al Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer's disease patients.  Ann Neurol.1996;40:265-266.Google Scholar
21.
Finckh  UMuller-Thomsen  TMann  U  et al High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.  Am J Hum Genet.2000;66:110-117.Google Scholar
22.
Hull  MFiebich  BLDykierek  P  et al Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139.  Eur Arch Psychiatry Clin Neurosci.1998;248:123-129.Google Scholar
23.
Rossor  MNFox  NCBeck  JCampbell  TCCollinge  J Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation [letter].  Lancet.1996;347:1560. Google Scholar
24.
Jorgensen  PBus  CPallisgaard  NBryder  MJorgensen  AL Familial Alzheimer's disease co-segregates with a Met146Ile substitution in presenilin-1.  Clin Genet.1996;50:281-286.Google Scholar
25.
Cervenakova  LBrown  PSandoval  F  et al Identification of presenilin-1 gene point mutations in early onset Alzheimer disease families [abstract].  Am J Hum Genet.1996;59:1454. Google Scholar
26.
Gustafson  LBrun  AEnglund  E  et al A 50-year perspective of a family with chromosome-14–linked Alzheimer's disease.  Hum Genet.1998;102:253-257.Google Scholar
27.
Essen-Möller  E A family with Alzheimer's disease.  Acta Psychiatr Neurol.1946;21:233-244.Google Scholar
28.
Sherrington  RRogaev  EILiang  Y  et al Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease.  Nature.1995;375:754-760.Google Scholar
29.
Morelli  LPrat  MILevy  EMangone  CACastano  EM Presenilin 1 Met146Leu variant due to an A→T transversion in an early-onset familial Alzheimer's disease pedigree from Argentina.  Clin Genet.1998;53:469-473.Google Scholar
30.
Sorbi  SNacmias  BForleo  P  et al Missense mutation of S182 gene in Italian families with early-onset Alzheimer's disease.  Lancet.1995;346:439-440.Google Scholar
31.
Campion  DDumanchin  CHannequin  D  et al Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.  Am J Hum Genet.1999;65:664-670.Google Scholar
32.
Cruts  MVan Broeckhoven  C Presenilin mutations in Alzheimer's disease.  Hum Mutat.1998;11:183-190.Google Scholar
33.
Scheuner  DEckman  CJensen  M  et al Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.  Nat Med.1996;2:864-870.Google Scholar
34.
Duff  KEckman  CZehr  C  et al Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1.  Nature.1996;383:710-713.Google Scholar
35.
De Jonghe  CCruts  MRogaeva  EA  et al Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Aβ42 secretion.  Hum Mol Genet.1999;8:1529-1540.Google Scholar
36.
Frommelt  PSchnabel  RKuhne  WNee  LPolinsky  R Familial Alzheimer's disease: a large multigeneration German kindred.  Alzheimer Dis Assoc Disord.1991;5:36-43.Google Scholar
37.
Kennedy  AMNewman  SKFrackowiak  RSJ  et al Chromosome 14 linked familial Alzheimer's disease: a clinico-pathological study of a single pedigree.  Brain.1995;118:185-205.Google Scholar
38.
Haltia  MViitanen  MSulkava  R  et al Chromosome 14–encoded Alzheimer's disease: genetic and clinicopathological description.  Ann Neurol.1994;36:362-367.Google Scholar
39.
Lampe  THBird  TDNochlin  D  et al Phenotype of chromosome 14–linked familial Alzheimer's disease in a large kindred.  Ann Neurol.1994;36:368-378.Google Scholar
40.
Mayeux  RStern  YSpanton  S Heterogeneity in dementia of the Alzheimer type: evidence of subgroups.  Neurology.1985;35:453-460.Google Scholar
41.
Fox  NCKennedy  AMHarvey  RJ  et al Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene: pedigree but not mutation specific age at onset provides evidence for a further genetic factor.  Brain.1997;120:491-501.Google Scholar
42.
Harvey  RJEllison  DHardy  J  et al Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine to serine (L250S) substitution at codon 250 of the presenilin 1 gene.  J Neurol Neurosurg Psychiatry.1998;64:44-49.Google Scholar
43.
Crook  RVerkkoniemi  APerez-Tur  J  et al A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.  Nat Med.1998;4:452-455.Google Scholar
44.
Mullan  MHoulden  HCrawford  FKennedy  ARogues  PRossor  M Age of onset in familial early-onset Alzheimer's disease correlates with genetic etiology.  Am J Med Genet.1993;48:129-130.Google Scholar
45.
Van Broeckhoven  CBackhovens  HCruts  M  et al APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease.  Neurosci Lett.1994;169:179-180.Google Scholar
46.
Axelman  KBasun  HLannfelt  L Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene.  Arch Neurol.1998;55:698-702.Google Scholar
47.
Lantos  PLLuthert  PJHanger  DAnderton  BHMullan  MRossor  M Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology.  Neurosci Lett.1992;137:221-224.Google Scholar
48.
McKeith  IGGalasko  DKosaka  K  et al Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.  Neurology.1996;47:1113-1124.Google Scholar
49.
Lippa  CFFujiwara  HMann  DM  et al Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.  Am J Pathol.1998;153:1365-1370.Google Scholar
50.
McKeith  IGPerry  EKPerry  RH Report of the second dementia with Lewy body international workshop: diagnosis and treatment: Consortium on Dementia with Lewy Bodies.  Neurology.1999;53:902-905.Google Scholar
Original Contribution
June 2001

Autopsy-Confirmed Familial Early-Onset Alzheimer Disease Caused by the L153V Presenilin 1 Mutation

Author Affiliations

From the Dementia Research Group, Institute of Neurology (Drs Janssen, Fox, Harvey, and Rossor), the Departments of Neuropathology (Dr Lantos) and Neuroscience (Dr Hanger), Institute of Psychiatry, the Medical Research Council Prion Unit, Department of Neurogenetics, Imperial College School of Medicine (Messrs Beck and Dickinson, Ms Campbell, and Dr Collinge), and the Departments of Clinical Neuropsychology (Dr Cipolotti) and Neuroradiology (Dr Stevens), National Hospital for Neurology and Neurosurgery, London, England.

Arch Neurol. 2001;58(6):953-958. doi:10.1001/archneur.58.6.953
Abstract

Background  Three affected individuals are described from a small English kindred with early-onset autosomal dominant familial Alzheimer disease (FAD) caused by a leucine-to-valine change at codon 153 (L153V) of the presenilin 1 (PSEN1) gene.

Methods  Clinical information on the pedigree was collected directly from family members and from hospital records. Samples of DNA were screened by means of direct sequencing of all coding exons of PSEN1. One patient underwent neuropathological examination.

Results  Mean age at onset of symptoms was 35.3 years (95% confidence interval [CI], 34.6-36.0 years); at death, 44.0 years (95% CI, 39.1-48.9 years). Mean duration of illness was 8.3 years (95% CI, 4.7-11.9 years). Myoclonus was a late feature in 1 patient; seizures were not reported in any subjects. Spastic paraparesis and extrapyramidal signs were absent. The neuropsychometric profile of 1 patient showed relatively preserved naming skills in the setting of global cognitive deficits. Results of neuropathological examination demonstrated the signature lesions of Alzheimer disease and the presence of occasional cortical Lewy bodies.

Conclusions  The PSEN1 L153V mutation lies in the main mutation cluster of PSEN1 in the second transmembrane domain. It causes early-onset FAD with clinical features similar to those of other reported FAD pedigrees.

×